Merck (UKEX:MRK) Cyclically Adjusted Book per Share: ₴699.08 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:MRK Merck & Co Inc UKEX:MRK
72 GF Score
Price ₴4,844.00
GF Value ₴4,649.63
! 8 Warning Signs
View Full Analysis

What is Merck Cyclically Adjusted Book per Share?

Merck UKEX:MRK 72 Cyclically Adjusted Book per Share is ₴699.08 as of Mar. 2026. GuruFocus rates UKEX:MRK with a GF Score™ of 72/100 and a GF Value™ of ₴4,649.63. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Merck's adjusted book value per share for the three months ended in Mar. 2026 was ₴828.964. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₴699.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merck's average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Merck was 11.30% per year. The lowest was -1.00% per year. And the median was 6.40% per year.

As of today (2026-07-16), Merck's current stock price is ₴4844.00. Merck's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₴699.08. Merck's Cyclically Adjusted PB Ratio of today is 6.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.75.


Merck  (UKEX:MRK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4844.00/699.08
=6.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Merck Cyclically Adjusted Book per Share Related Terms


Merck Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Merck's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck Cyclically Adjusted Book per Share Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 580.30 590.23 821.94 787.85

Merck Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 917.96 1,045.78 991.54 787.85 699.08

UKEX:MRK vs AMGN, ABBV, GILD: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Merck's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Cyclically Adjusted PB Ratio falls into.


UKEX:MRK
72GF Score
Merck & Co Inc UKEX:MRK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=828.964/330.2130*330.2130
=828.964

Current CPI (Mar. 2026) = 330.2130.

Merck Quarterly Data

Book Value per Share CPI Adj_Book
201606 699.584 241.018 958.483
201609 706.842 241.428 966.783
201612 650.814 241.432 890.136
201703 648.696 243.801 878.618
201706 645.742 244.955 870.496
201709 626.027 246.819 837.546
201712 568.206 246.524 761.098
201803 558.006 249.554 738.361
201806 543.660 251.989 712.426
201809 544.175 252.439 711.830
201812 459.593 251.233 604.075
201903 475.758 254.202 618.018
201906 480.444 256.143 619.376
201909 469.497 256.759 603.811
201912 455.330 256.974 585.102
202003 463.305 258.115 592.718
202006 487.715 257.797 624.716
202009 514.837 260.280 653.165
202012 446.506 260.474 566.053
202103 475.016 264.877 592.186
202106 586.608 271.696 712.950
202109 632.510 274.310 761.412
202112 674.135 278.802 798.445
202203 721.565 287.504 828.754
202206 761.762 296.311 848.918
202209 783.104 296.808 871.240
202212 808.694 296.797 899.744
202303 823.641 301.836 901.075
202306 679.941 305.109 735.886
202309 725.985 307.789 778.877
202312 662.433 306.746 713.111
202403 711.188 312.332 751.903
202406 766.995 314.175 806.149
202409 784.305 315.301 821.398
202412 817.641 315.605 855.486
202503 857.258 319.799 885.174
202506 873.420 322.561 894.140
202509 930.222 324.800 945.725
202512 948.637 324.054 966.667
202603 828.964 330.213 828.964

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₴699.08 mean?
Merck (UKEX:MRK) has a Cyclically Adjusted Book per Share of ₴699.08 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors.
Is Merck's Cyclically Adjusted Book per Share too high?
Merck's current Cyclically Adjusted Book per Share is ₴699.08. Overall, Merck has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Merck's Cyclically Adjusted Book per Share compare to AMGN and ABBV?
Merck's Cyclically Adjusted Book per Share of ₴699.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors. Merck's current Cyclically Adjusted Book per Share is ₴699.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Merck (UKEX:MRK) has a current Cyclically Adjusted Book per Share of ₴699.08. The stock's GF Value™ is ₴4,649.63, compared to a current price of ₴4,844.00 — trading 4.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₴699.08. Merck's overall GF Score™ is 72/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Merck (UKEX:MRK), the current Cyclically Adjusted Book per Share is ₴699.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (UKEX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of ₴4,844.00 is trading 4.2% above its estimated GF Value™ of ₴4,649.63.

Key valuation signals for UKEX:MRK:

  • Cyclically Adjusted Book per Share: ₴699.08
  • GF Value™: ₴4,649.63 vs. price of ₴4,844.00 (4.2% above fair value)
  • GF Score™: 72/100 with 8 warning signs

No single metric tells the full story. See the UKEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
72GF Score

Get the complete analysis for UKEX:MRK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴4,844.00
Price
₴4,649.63
GF Value